Autoimmunity in Gestational Diabetes Mellitus

Alok Kumar, Alberto De Leiva, Rosa Corcoy*

*Autor corresponent d’aquest treball

Producció científica: Capítol de llibreCapítolRecercaAvaluat per experts

3 Cites (Scopus)

Resum

Up to 16.2% of pregnant women have some form of hyperglycemia, and an estimated 85% of them are due to gestational diabetes mellitus (GDM). Usually, the impairment of glucose tolerance in GDM is the result of relative insulin deficiency not due to autoimmune mechanisms. But autoimmune mechanisms similar to those in classical type 1 diabetes mellitus (DM-1A) and latent autoimmune diabetes in adults also play a pathophysiological role in a subset of GDM patients. Women with autoimmune GDM are those with glucose intolerance in pregnancy depicting in their sera diabetes-related autoantibodies (DRAs). The prevalence varies depending upon study population, methodology, and type of antibody. Women with GDM who display DRA positivity have higher rates of insulin requirement and a higher risk of abnormal glucose tolerance after pregnancy, including DM-1A.

Idioma originalAnglès
Títol de la publicacióFrontiers in Diabetes
Pàgines234-242
Nombre de pàgines9
DOIs
Estat de la publicacióPublicada - 2019

Sèrie de publicacions

NomFrontiers in Diabetes
Volum28
ISSN (imprès)0251-5342
ISSN (electrònic)1662-2995

Fingerprint

Navegar pels temes de recerca de 'Autoimmunity in Gestational Diabetes Mellitus'. Junts formen un fingerprint únic.

Com citar-ho